Overview

Safety And Efficacy Of Empagliflozin In Pakistani Muslim Population With Type Ii Diabetes Mellitus

Status:
Completed
Trial end date:
2020-09-28
Target enrollment:
Participant gender:
Summary
To compare the safety and efficacy of empagliflozin versus other treatments in Pakistani Muslim population with type II diabetes mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
Getz Pharma
Treatments:
Empagliflozin